Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
Lung ultrasound works well in children with COVID-19
Ultrasound offers several benefits over other imaging modalities, too.
News
FDA makes Ilaris the first approved treatment for adult-onset Still’s disease
Canakinumab (Ilaris) had previously been approved for the juvenile-onset form of Still’s disease, also known as systemic juvenile idiopathic...
News
FDA approves ixekizumab for nonradiographic axSpA
This is the first IL-17A antagonist to receive FDA approval for this indication.
News
Ob.gyns. income is in the middle of the pack of specialties
Among ob.gyns., 38% report that gratitude and relationships with patients is the most rewarding part of their job.
News
Sensitizer prevalent in many hypoallergenic products for children
More than half of the shampoo products labeled hypoallergenic contained cocamidopropyl betaine.
News
Suicide increased 35% during 1999-2018 in the U.S.
Rates were significantly higher in rural areas than urban ones in 2018.
News
FDA approves first generic albuterol inhaler
The FDA had recently released guidance on steps companies need to take to submit complete applications for products like this.
News
FDA approves recombinant treatment for hemophilia A or B with inhibitors
The new treatment is made using milk from transgenic rabbits.
News
FDA approves ixekizumab for pediatric plaque psoriasis
A phase 3 study showed a safety profile similar in both pediatric and adult patients, albeit with greater rates of conjunctivitis, influenza, and...
News
FDA approves ozanimod for relapsing and secondary progressive forms of MS
It is the only approved sphingosine-1-phosphate receptor modulator with no requirement for genetic testing or label-based first-dose observation...
News
New ASAM guideline released amid COVID-19 concerns
During the COVID-19 pandemic, “it is especially important” for clinicians to ensure that individuals with OUD continue to receive evidence-based...
News
More inclusive assessment better predicts cognitive impairment in very preterm children
Tests at age 6 years provided the best diagnostic accuracy for finding risk for cognitive impairment at age 12 years.